Skip Navigation


JAC Advance Access originally published online on November 7, 2005
Journal of Antimicrobial Chemotherapy 2005 56(6):1166-1168; doi:10.1093/jac/dki387
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/6/1166    most recent
dki387v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hurdle, J. G.
Right arrow Articles by Bradley, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hurdle, J. G.
Right arrow Articles by Bradley, S. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2005

In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis

Julian G. Hurdle1, Alex J. O'Neill1, Lona Mody2, Ian Chopra1 and Suzanne F. Bradley2,3,*

1 School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK; 2 Division of Geriatric Medicine, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, The University of Michigan Medical School, Ann Arbor, MI, USA; 3 Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Ann Arbor Healthcare System, The University of Michigan Medical School, Ann Arbor, MI, USA

Received 24 July 2005; returned 26 August 2005; revised 26 September 2005; accepted 28 September 2005


* Correspondence address. GRECC 11G, Veterans Affairs Ann Arbor Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA. Tel: +1-734-761-7686; Fax: +1-734-761-7489; E-mail: sbradley{at}umich.edu

Objectives: We examined the molecular basis of the emergence of mupirocin resistance in a methicillin-resistant Staphylococcus aureus (MRSA) strain colonizing a nursing home resident undergoing mupirocin prophylaxis.

Patient and methods: A persistent carrier of mupirocin-susceptible MRSA participated in a trial of mupirocin for nasal decolonization among nursing home residents. During prophylaxis a high-level mupirocin-resistant MRSA emerged in the nasal isolates from this patient. S. aureus and coagulase-negative staphylococci were isolated prior to, during and after 14 days of mupirocin treatment. The staphylococcal isolates and their plasmids were examined by molecular genetic methods.

Results: All mupirocin-susceptible and -resistant MRSA isolates possessed the same genotype. The patient was also colonized by a single mupirocin-resistant Staphylococcus epidermidis strain. The mupirocin-resistant MRSA and S. epidermidis strains harboured identical plasmids that carried the mupA determinant and genes for conjugative DNA transfer in staphylococci. These plasmids could be transferred in vitro from both clinical isolates to S. aureus RN2677.

Conclusions: The MRSA strain contained a conjugative plasmid expressing mupA that was identical with that found in the S. epidermidis strain which colonized the patient. These findings suggest that transfer of mupA from S. epidermidis to MRSA probably occurred during mupirocin prophylaxis.

Keywords: MRSA , nasal decolonization , coagulase-negative , staphylococci


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
F. McLaws, I. Chopra, and A. J. O'Neill
High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis
J. Antimicrob. Chemother., May 1, 2008; 61(5): 1040 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. G. Driscoll, C. L. Young, and U. A. Ochsner
Transient Loss of High-Level Mupirocin Resistance in Staphylococcus aureus Due to MupA Polymorphism
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2247 - 2248.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Perez-Roth, C. Lopez-Aguilar, J. Alcoba-Florez, and S. Mendez-Alvarez
High-Level Mupirocin Resistance within Methicillin-Resistant Staphylococcus aureus Pandemic Lineages.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3207 - 3211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. E. Craven and R. A. Duncan
Preventing Ventilator-associated Pneumonia: Tiptoeing through a Minefield.
Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1297 - 1298.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.